Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/2/2021
SIETES contiene 93212 citas

 1 a 20 de 25 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, Demets D, Evans S, Law M, McMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercok P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532-61. [Ref.ID 100988]
3.Tiene citas relacionadas Cita con resumen
Waller P, Evans S. Mediator: who's to blame?. Lancet 2011;377:2022-03. [Ref.ID 91300]
4.Tiene citas relacionadas Cita con resumen
Douglas I, Evans S, Smeeth L. Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ 2011;342:810. [Ref.ID 90375]
5.Enlace a cita original
Schoonen WM, Thomas SL, Somers EC, Smeeth L, Kim J, Evans S, Hall AJ. Do selected drugs increase the risk of lupus? A metched case-control study. Br J Clin Pharmacol 2010;70:588-96. [Ref.ID 89442]
6. Cita con resumen
Smeeth L, Douglas I, Hall AJ, Hubbard R, Evans S. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol 2009;67:99-109. [Ref.ID 84984]
7. Cita con resumen
Al-Marzouki S, Roberts I, Evans S, Marshall T. Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet. Lancet 2008;372:201. [Ref.ID 83620]
8.Tiene citas relacionadas
Diug B, Lowthian J, Evans S. Warfarin versus aspirin for stroke prevention (BAFTA). Lancet 2007;370:1606. [Ref.ID 81476]
9. Cita con resumen
Roberts I, Smith R, Evans S. Doubts over head injury studies. BMJ 2007;334:392-4. [Ref.ID 79361]
11. Cita con resumen
Clifford DB, Evans S, Yang Y, Acosta EP, Goodkin K, Tashima K, Simpson D, Dorfman D, Ribaudo H, Gulick RM, for the A5097s Study Team. Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med 2005;143:714-21. [Ref.ID 75648]
12.Tiene citas relacionadas
Al-Marzouki S, Evans S, Marshall T, Roberts I. Are these data real? Statistical methods for the detection of data fabrication in clinical trials. BMJ 2005;331:267-70. [Ref.ID 74548]
13.Tiene citas relacionadas Cita con resumen
Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005;330:389. [Ref.ID 72768]
14.Tiene citas relacionadas
Waller P, van Puijenbroek E, Egberts A, Evans S. The reporting odds ratio versus the proportional reporting ratio: 'deuce'. Pharmacoepidemiol Drug Saf 2004;13:525-6. [Ref.ID 71253]
15.Tiene citas relacionadas
Schroter S, Black N, Evans S, Carpenter J, Godlee F, Smith R. Effects of training on quality of peer review: randomised controlled trial. BMJ 2004;328:673-5. [Ref.ID 69548]
17.Tiene citas relacionadas
Evans S, Pocock S. Societal responsibilities of clinical trial sponsors. BMJ 2001;322:569-70. [Ref.ID 55478]
18.Tiene citas relacionadas
Ranstam J, Buyse M, George SL, Evans S, Geller NL, Scherrer B, Lesaffre E, Murray G, Edler L, Hutton JL, Colton T, Lachenbruch P, for the ISCB Subcommittee on Fraud. Fraud in medical research: an international survey of biostatisticians. Control Clin Trial 2000;21:415-27. [Ref.ID 52950]
Almond DS, Green CJ, Geurin DM, Evans S. Norwegian scabies misdiagnosed as an adverse drug reaction. BMJ 2000;320:35-6. [Ref.ID 48690]
Buyse M, George SL, Evans S, Geller NL, Ranstam J, Scherrer B, Lesaffre E, Murray G, Edler L, Hutton J, Colton T, Lachenbruch P, Verma BL. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med 1999;18:3435-51. [Ref.ID 48619]
Seleccionar todas
 1 a 20 de 25 siguiente >>